BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34418249)

  • 1. Late endosomal/lysosomal accumulation of a neurotransmitter receptor in a cellular model of Smith-Lemli-Opitz syndrome.
    Sharma A; Kumar GA; Chattopadhyay A
    Traffic; 2021 Oct; 22(10):332-344. PubMed ID: 34418249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling by the human serotonin(1A) receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome.
    Paila YD; Murty MR; Vairamani M; Chattopadhyay A
    Biochim Biophys Acta; 2008 Jun; 1778(6):1508-16. PubMed ID: 18381059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smith-Lemli-Opitz syndrome: A pathophysiological manifestation of the Bloch hypothesis.
    Chattopadhyay A; Sharma A
    Front Mol Biosci; 2023; 10():1120373. PubMed ID: 36714259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sterol balance in the Smith-Lemli-Opitz syndrome. Reduction in whole body cholesterol synthesis and normal bile acid production.
    Steiner RD; Linck LM; Flavell DP; Lin DS; Connor WE
    J Lipid Res; 2000 Sep; 41(9):1437-47. PubMed ID: 10974051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol storage defect in RSH/Smith-Lemli-Opitz syndrome fibroblasts.
    Wassif CA; Vied D; Tsokos M; Connor WE; Steiner RD; Porter FD
    Mol Genet Metab; 2002 Apr; 75(4):325-34. PubMed ID: 12051964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.
    Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N
    J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant pathways in the late stages of cholesterol biosynthesis in the rat. Origin and metabolic fate of unsaturated sterols relevant to the Smith-Lemli-Opitz syndrome.
    Ruan B; Tsai J; Wilson WK; Schroepfer GJ
    J Lipid Res; 2000 Nov; 41(11):1772-82. PubMed ID: 11060346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in membrane caveolae and BKCa channel activity in skin fibroblasts in Smith-Lemli-Opitz syndrome.
    Ren G; Jacob RF; Kaulin Y; Dimuzio P; Xie Y; Mason RP; Tint GS; Steiner RD; Roullet JB; Merkens L; Whitaker-Menezes D; Frank PG; Lisanti MP; Cox RH; Tulenko TN
    Mol Genet Metab; 2011 Nov; 104(3):346-55. PubMed ID: 21724437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.
    Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y
    J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant RSH/Smith-Lemli-Opitz syndrome with atypical sterol metabolism.
    Anderson AJ; Stephan MJ; Walker WO; Kelley RI
    Am J Med Genet; 1998 Aug; 78(5):413-8. PubMed ID: 9714006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of cholesterol and 7-dehydrocholesterol on ligand binding of solubilized hippocampal serotonin1A receptors: implications in SLOS.
    Chattopadhyay A; Paila YD; Jafurulla M; Chaudhuri A; Singh P; Murty MR; Vairamani M
    Biochem Biophys Res Commun; 2007 Nov; 363(3):800-5. PubMed ID: 17904101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compromised phagosome maturation underlies RPE pathology in cell culture and whole animal models of Smith-Lemli-Opitz Syndrome.
    Ramachandra Rao S; Pfeffer BA; Más Gómez N; Skelton LA; Keiko U; Sparrow JR; Rowsam AM; Mitchell CH; Fliesler SJ
    Autophagy; 2018; 14(10):1796-1817. PubMed ID: 29979914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acid biosynthesis in Smith-Lemli-Opitz syndrome bypassing cholesterol: Potential importance of pathway intermediates.
    Abdel-Khalik J; Hearn T; Dickson AL; Crick PJ; Yutuc E; Austin-Muttitt K; Bigger BW; Morris AA; Shackleton CH; Clayton PT; Iida T; Sircar R; Rohatgi R; Marschall HU; Sjövall J; Björkhem I; Mullins JGL; Griffiths WJ; Wang Y
    J Steroid Biochem Mol Biol; 2021 Feb; 206():105794. PubMed ID: 33246156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feedback inhibition of the cholesterol biosynthetic pathway in patients with Smith-Lemli-Opitz syndrome as demonstrated by urinary mevalonate excretion.
    Pappu AS; Steiner RD; Connor SL; Flavell DP; Lin DS; Hatcher L; Illingworth DR; Connor WE
    J Lipid Res; 2002 Oct; 43(10):1661-9. PubMed ID: 12364550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome.
    Ginat S; Battaile KP; Battaile BC; Maslen C; Gibson KM; Steiner RD
    Mol Genet Metab; 2004; 83(1-2):175-83. PubMed ID: 15464432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome.
    Linck LM; Lin DS; Flavell D; Connor WE; Steiner RD
    Am J Med Genet; 2000 Aug; 93(5):360-5. PubMed ID: 10951458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased cerebral spinal fluid neurotransmitter levels in Smith-Lemli-Opitz syndrome.
    Sparks SE; Wassif CA; Goodwin H; Conley SK; Lanham DC; Kratz LE; Hyland K; Gropman A; Tierney E; Porter FD
    J Inherit Metab Dis; 2014 May; 37(3):415-20. PubMed ID: 24500076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol biosynthesis from birth to adulthood in a mouse model for 7-dehydrosterol reductase deficiency (Smith-Lemli-Opitz syndrome).
    Marcos J; Shackleton CH; Buddhikot MM; Porter FD; Watson GL
    Steroids; 2007 Oct; 72(11-12):802-8. PubMed ID: 17714750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualisation of cholesterol and ganglioside GM1 in zebrafish models of Niemann-Pick type C disease and Smith-Lemli-Opitz syndrome using light sheet microscopy.
    Cook SR; Bladen C; Smith J; Maguire E; Copner J; Fenn GD; Wager K; Waller-Evans H; Lloyd-Evans E
    Histochem Cell Biol; 2020 Nov; 154(5):565-578. PubMed ID: 33079236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultraviolet A sensitivity in Smith-Lemli-Opitz syndrome: Possible involvement of cholesta-5,7,9(11)-trien-3 beta-ol.
    Chignell CF; Kukielczak BM; Sik RH; Bilski PJ; He YY
    Free Radic Biol Med; 2006 Jul; 41(2):339-46. PubMed ID: 16814115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.